Increased Immune Gene Expression and Immune Cell Infiltration in High-Grade Astrocytoma Distinguish Long-Term from Short-Term Survivors-Reference-Cited by-同舟云学术

Increased Immune Gene Expression and Immune Cell Infiltration in High-Grade Astrocytoma Distinguish Long-Term from Short-Term Survivors

Published:2012-07-16 Issue:4 Volume:189 Page:1920-1927
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Donson Andrew M.,Birks Diane K.,Schittone Stephanie A.,Kleinschmidt-DeMasters Bette K.,Sun Derrick Y.,Hemenway Molly F.,Handler Michael H.,Waziri Allen E.,Wang Michael,Foreman Nicholas K.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference42 articles.

1. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

2. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy.;Prados;J. Clin. Oncol.,1999

3. Recursive Partitioning Analysis of Prognostic Factors in Three Radiation Therapy Oncology Group Malignant Glioma Trials

4. MGMTGene Silencing and Benefit from Temozolomide in Glioblastoma

5. IDH1andIDH2Mutations in Gliomas

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Case of Long-Term Survival After Glioblastoma, IDH-Wild Type;The Neurologist;2024-05-27

2. The immunological landscape of peripheral blood in glioblastoma patients and immunological consequences of age and dexamethasone treatment;Frontiers in Immunology;2024-01-18

3. Transcriptomic analysis of esophageal cancer reveals hub genes and networks involved in cancer progression;Computers in Biology and Medicine;2023-06

4. Cellular and molecular features related to exceptional therapy response and extreme long‐term survival in glioblastoma;Cancer Medicine;2023-02-12

5. A Toolkit for Profiling the Immune Landscape of Pediatric Central Nervous System Malignancies;Frontiers in Immunology;2022-04-07